RE:RE:Catalyst Update (and shadytree error) every fall, post financing... same old stale stories... same pattern.
he gives us:
1. wild price targets.
2. Tell everyone there will be an uptick in enrolment.
3. That Dimi will have great new partners
4. the new people that threw in on financing want to see money so price will go up.
feel free, read his posts yourself and compare it to the charts.
BayStreetWild wrote:
this was Mercedes' man last year giving us his targets and predictions for 2021. Notice a pattern?
how many of these came true? 0.. yes.. 0
mercedesman wrote: Go back and check your obsessive records....I revised the $ 0.80 ST target to $ 0.68 as a result of See-to 's most dilutive financing.
And with that, I remain at a target that is less than 25% of Paradigm's latest target (Sept. 2021)
Of course, I am counting on one or more of the following catalysts as a head wind...any number of which should be close....along with a genuine college effort to tell the excellent story (for a change)...We shall soon see (Vincenza, Benzinger, etc.) * * *
PMX Related 1) an announcement of an uptick in enrollment might be material given that the latest Covid spike in the US has apparently peaked and cases are now in decline. Up to 15 hospitals now recruiting ? Kellum is now apparently spinning his rolodex (and Rolex) and pushing the hospitals to git 'a move on. When a top .0028% Doc calls you answer the phone. 2) Good to great results triggering "an event" given the favourable nature of the Trial (see Euphas, efficacy, Open Label, 2:1 ratio, Bayesian)
3) AGP deciding (being allowed to?) to tell the story state-side, as a natural follow-up to their large Bought Deal. NYC Investment Houses are typically do not commit their $ to hold for the LT...they prefer to rake it in as a Casino might, rather than gamble as a player might....because they like a sure thing.
4) Other ? DIALCO Related
1) Announcement of Clincs participating in the DIMI Trial? Hope it's one of Da bigger ones.
2) Announcement ot the first patient in the DIMI Home Use Trial ? Let's start the countdown from say 35 shall we? If # 1 above is a big player, will it happen rather quickly, vs a slow drip? All they need is one or two volunteers from a handful of their clinics.
3) A SAMI Distribtuion Agreement ? Lot's of potential canDAdates...will take some brains over Brawn. Bring me my Meds and tonic while we wait.
4) New equity partner, that establishes a higher value for the Dialco portion, thereby impacting the overall MC of the Company ?
5) Other?
EAA Related
1) I'm no Doctor, but rumour has it that Endotoxemia almost always leads to Septic Shock. Endotoxemia has a high mortality rate. The EAA is the only FDA approved diagnostic that measures for endotemia. Will there finally be a recognition that a much higher percentage of ICU patients should be screened for Endotoxemia using the EAA - in much the same way someone with a fever or other sepsis/flu/Covid like symptoms, might be screened (but currently perhaps, and for some reason, only for Covid and perhaps lesser so for the flu)?
2) Worldwide uptake (EAA rights ate global) as the world sloooowly catches on to the importance of diagnostics and precision medicine. Even in Japan?
Plus why buy EAA's unless and until you can actually do something about Endotoxins.
3) Other?
The ponies must be getting anxious to get out of their stables and over to the gate and on to the track, in order to strut their stuff. As unknowns they may be long-shots, but if they win/place and show, there could be a huge payday at the track.